Current therapeutic options for treating primary hyperhidrosis
- PMID: 15121105
- DOI: 10.1016/j.ejvs.2004.01.023
Current therapeutic options for treating primary hyperhidrosis
Abstract
Severe hyperhidrosis can cause extreme embarrassment that may lead to social and professional isolation. Therapeutic strategies to hyperhidrosis should employ the least invasive treatment that provides effective symptom control. The treatment options available for control of hyperhidrosis, non-surgical or surgical, differ in their invasiveness and efficacy. Mechanisms of action of antiperspirants, iontophoresis, cholinergic inhibitor drugs, botulinum toxin, and surgical sympathectomy are reviewed. There is little published evidence in the form of comparative randomised trials to support the use of one treatment over another. However, authors have tended to recommend those therapies that are available to their speciality. Specific therapies should be tailored to the patient's symptoms to gain maximum symptomatic improvement with minimum invasiveness and side-effects. To achieve this, the full range of treatment options should be available to, or accessible by the consulting doctor in order for the patient to have a meaningful choice.
Comment in
-
Current treatment options for treating primary hyperhidrosis.Eur J Vasc Endovasc Surg. 2004 Oct;28(4):453. doi: 10.1016/j.ejvs.2004.07.015. Eur J Vasc Endovasc Surg. 2004. PMID: 15350574 No abstract available.
Similar articles
-
Current treatment options for treating primary hyperhidrosis.Eur J Vasc Endovasc Surg. 2004 Oct;28(4):453. doi: 10.1016/j.ejvs.2004.07.015. Eur J Vasc Endovasc Surg. 2004. PMID: 15350574 No abstract available.
-
Current therapeutic strategies for hyperhidrosis: a review.Eur J Dermatol. 2002 May-Jun;12(3):219-23. Eur J Dermatol. 2002. PMID: 11978559 Review.
-
Primary pediatric hyperhidrosis: a review of current treatment options.Pediatr Dermatol. 2008 Nov-Dec;25(6):591-8. doi: 10.1111/j.1525-1470.2008.00782.x. Pediatr Dermatol. 2008. PMID: 19067862 Review.
-
Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.Ann Vasc Surg. 2009 Jan-Feb;23(1):1-7. doi: 10.1016/j.avsg.2008.04.014. Epub 2008 Jul 10. Ann Vasc Surg. 2009. PMID: 18619780
-
Treatment of hyperhidrosis.J Drugs Dermatol. 2003 Oct;2(5):521-7. J Drugs Dermatol. 2003. PMID: 14558400 Review.
Cited by
-
Endoscopic thoracic sympathectomy for long QT syndrome.Ir J Med Sci. 2008 Jun;177(2):167-9. doi: 10.1007/s11845-008-0134-2. Epub 2008 Feb 23. Ir J Med Sci. 2008. PMID: 18297371
-
Long-Term Use of Antiperspirant is Associated with a Low Risk of Postoperative Complications in Patients with Axillary Osmidrosis.Clin Cosmet Investig Dermatol. 2022 Oct 30;15:2335-2343. doi: 10.2147/CCID.S381380. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36339944 Free PMC article.
-
Optimal targeting of sympathetic chain levels for treatment of palmar hyperhidrosis: an updated systematic review.Surg Endosc. 2017 Nov;31(11):4357-4369. doi: 10.1007/s00464-017-5508-y. Epub 2017 Apr 7. Surg Endosc. 2017. PMID: 28389800
-
A retrospective cohort study of T3 versus T4 thoracoscopic sympathectomy for primary palmar hyperhidrosis and primary palmar hyperhidrosis with axillary and plantar sweating.Wideochir Inne Tech Maloinwazyjne. 2020 Sep;15(3):488-495. doi: 10.5114/wiitm.2019.89656. Epub 2019 Nov 11. Wideochir Inne Tech Maloinwazyjne. 2020. PMID: 32904609 Free PMC article.
-
Efficacy and Safety of Treatments for Primary Palmar Hyperhidrosis: A Systematic Review Assessing Patient-Centric Outcomes.Dermatol Res Pract. 2025 Aug 20;2025:8867838. doi: 10.1155/drp/8867838. eCollection 2025. Dermatol Res Pract. 2025. PMID: 40881604 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources